However, in KRAS-mutated pancreatic cancer, Li et al. described that TAP1 overexpression increased resistance to MEK inhibitors by facilitating drug transport out of cells and promoting cancer stemness48. Here, MAP2K7 is linked to familial pancreatic carcinoma.